Vishnu Chemicals manufactures specialty chemicals, primarily focusing on chromium derivatives, barium products, and newly commercialized strontium carbonate, serving domestic and export markets with a roughly 45:55 domestic-to-export revenue mix. The company holds a 60% market share in India for both chromium chemicals and PBS, operating an 80,000-tonne sodium dichromate capacity and a 90,000-tonne barium capacity. While barium EBITDA margins sustain at a robust 25%, the chromium segment has been stuck around 15% for four to five quarters due to elevated raw material prices, dragging consolidated EBITDA margins to 15% in Q3 FY26 against a targeted 20%. For a converter business turning commodity chrome ore into specialized derivatives, sustained blended EBITDA margins below 18% indicate that current economics are average, as the company lacks immediate pricing power to offset input cost inflation while awaiting backward integration.
The economic persistence of this business relies heavily on qualification cycles and structural cost advantages rather than pure scale. Barium chemicals benefit from a steep learning curve and high working capital intensity, making it the lowest-cost producer even compared to Chinese peers, while an 84% EU anti-dumping duty on Chinese barium carbonate has allowed 10-15% price increases in Europe. Strontium carbonate offers a temporary moat as the sole Indian manufacturer, filling a 24,000-tonne supply gap left by a Mexican facility fire, though global competitor Kandelium holds over 70% market share with fungible capacity. Chromium chemicals are mission-critical for defense and aerospace applications, making them hard to substitute, but the segment remains exposed to commodity ore pricing until backward integration completes, meaning the current moat is operational rather than structural.
The next 18-24 months hinge on a massive capex cycle of INR360 crores aimed at transforming the cost structure and product mix by FY28. The South Africa chrome ore mine, acquired in November 2025 for INR20-25 crores, is expected to commence production by August 2026, with volumes flowing into India from Q3 FY27 to eventually satisfy 90% of raw material needs. Concurrently, a 10,000-tonne DMSO facility, a 6,000-tonne chrome metal plant, and a 20,000-tonne chrome oxide green expansion are slated for commercialization by FY28, supported by a 10-year binding take-or-pay supply agreement with a European client. If executed, gross margins should expand from 44.8% in Q3 FY26 toward 50%, driving consolidated EBITDA margins to the 20% target by FY28.
Management's walk-talk reveals a pattern of delayed milestones and under-delivered near-term promises. In May 2025, guidance stood at 15-20% revenue growth for FY26 and 20% EBITDA margins within two years, but 9M FY26 revenue grew only 10% to INR1,159 crores, and EBITDA margins remain at 15%. Strontium carbonate commercialization slipped from mid-June 2025 to Q2 FY26, with customer approvals still pending, while the South Africa mine acquisition closure slipped from November 2025 to a phased Q1 FY27 start. Capex estimates have also crept up from INR180-190 crores in FY26 to a total outlay of INR200-250 crores, funded through internal accruals and debt, though the balance sheet remains comfortable with net debt to equity at 0.25x as of June 2025.
Earnings visibility depends entirely on the timely commissioning of the South Africa mine and new specialty chemical plants, as 9M FY26 PAT growth of 12.7% cannot bridge the gap to the 20% EBITDA target without raw material security. The single most important falsifier is the South Africa mine timeline, given that transfer pricing regulations and statutory clearances have already caused delays, and any further slippage would leave chromium margins exposed to elevated ore prices. Additionally, logistics costs threatening to exceed 20% of revenues in Q2 FY27 due to geopolitical tensions could erode the gross margin expansion needed to reach the 50% target, making the FY28 margin goal a high-risk execution bet rather than a linear progression.
companyname: Vishnu Chemicals Limited ticker: VISHNU sector: Speciality Chemicals / Inorganic Chemicals Vishnu Chemicals Limited (VCL) manufactures speciality inorganic chemicals across three chemistries: Chromium, Barium and Strontium. The company has 35+ years of manufacturing history, operates 7 manufacturing units across the Group (4 in Andhra Pradesh, 1 in Telangana, 1 in Chhattisgarh and 1 in South Africa), employs 1,500+ people and ships to 50+ countries. In FY 2025-26 it recorded its hi...
Read the full report →capex, margin expansion, new product segment, acquisition inorganic
EBITDA margins to reach 20% by FY28
Guidance maintainedmixed
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Vishnu Chemicals Limited and 4,900+ companies.
5-day free pass. No card required.